liposomal glutathione parkinson's Neurotransmitter Dysregulation in Disease: Pathophysiological Insights and Therapeutic Perspectives Phytomedicine nanoformulations for Parkinson's disease
Description
Rodrigo et al., 2014)
Any reference to research peptides is strictly limited to discussion of laboratory and research purposes only
Ultimately, this review provides a comprehensive roadmap for advancing ferroptosis-targeted therapies from the laboratory to clinical ophthalmology
We address this challenge by utilizing liposomal delivery
doi: 10.1016/j.fsi.2023.108817
As ebselen is already an FDA-approved drug, its repurposing as a radioprotective drug may be easier compared to any other new synthetic drug substance
